Cell and Gene Therapies for Refractory Epilepsy

E-ISSN： 1875-6190|5|2|115-125

ISSN： 1570-159X

Source： Current Neuropharmacology, Vol.5, Iss.2, 2007-06, pp. : 115-125

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bexarotene in combination with PUVA may be a treatment option in patients with cutaneous T-cell lymphoma refractory to multiple single-agent therapies

Inpharma, Vol. 1, Iss. 1467, 2004-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Cell and Gene Therapies in Cardiovascular Disease with Special Focus on the No Option Patient

Current Gene Therapy, Vol. 6, Iss. 6, 2006-12 ,pp. : 609-623

Bentham Science Publishers

Access to resources Recommend Favorite

Refractory epilepsy genetically determined?

Inpharma, Vol. 1, Iss. 1383-1384, 2003-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Topiramate as an Adjunctive Treatment for Refractory Partial Epilepsy in the Elderly

By Zhang L Huang J Zhuang J-H Huang L-Q Zhao Z-X

The Journal of International Medical Research, Vol. 39, Iss. 2, 2011-03 ,pp. : 408-415

Field House Publishing

Access to resources Recommend Favorite

Newer antipsychotics benefit those refractory to conventional therapies

Inpharma, Vol. 1, Iss. 1353, 2002-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite